About Pradip Majumder
Form D filings for Praesidia Biotherapeutics from 2021 to 2024 list Pradip Majumder as executive officer.
Pradip Majumder first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Pradip Majumder in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Pradip Majumder works with at each company, as listed on that company's latest Form D.
Praesidia Biotherapeutics, Inc. · Form D/A, Jul 17, 2024